Pozen/Tribute

(SEDAR filing: 6 November 2015) Circular of Tribute Pharmaceuticals Canada Inc. ("Trbute") respecting its proposed acquisition by ARLZ CA Acquisition Corp. ("Can Merger Sub"), a wholly-owned subsidiary of Aralez Pharmaceuticals Limited) ("Parent") and respecting the merger of US Merger Sub into POZEN Inc. ("Pozen") (2976 K). Fogler and DLA Piper/Troutman Sanders and DLA Piper (U.S.)
Summaries
Summary Under
Tax Topics - Public Transactions - Mergers & Acquisitions - Cross-Border Acquisitions - Inbound - New NR Holdco (Inversion)
Acquisition of Pozen and Tribute by Irish holdco
Overview

Tribute is proposing an inversion transaction with Pozen, a Delaware public company, which would result in both companies being held...

The text of this content is paywalled except for the first five days of each month. Subscribe or log in for unrestricted access.

Summary Under
Tax Topics - Public Transactions - Other - Continuances/Migrations - Inversions
Acquisition of Pozen and Tribute by Irish holdco
Overview

Tribute is proposing an inversion transaction (targeted to be completed in Q4, 2015) with Pozen, a Delaware public company, which would...

The text of this content is paywalled except for the first five days of each month. Subscribe or log in for unrestricted access.